Trump administration drops defense of ‘most favored nation’ price controls, leaves issue in Biden’s hands

In the face of defeats in three federal courts, the Trump administration has abandoned its attempt to use an administrative shortcut to impose a “most favored nation” international reference pricing scheme on Medicare Part B drugs, leaving decisions about pursing the policy to the Biden administration. 

The Department of Justice notified federal courts Friday that it will not appeal injunctions blocking implementation of the MFN rule that courts issued in cases filed by BIO and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN). ...